Polaris Wealth Advisory Group LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,120 shares of the healthcare conglomerate’s stock after buying an additional 398 shares during the period. Polaris Wealth Advisory Group LLC’s holdings in UnitedHealth Group were worth $798,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC increased its stake in shares of UnitedHealth Group by 0.6% during the fourth quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock worth $18,433,841,000 after buying an additional 295,642 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of UnitedHealth Group by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock worth $13,318,678,000 after buying an additional 1,881,407 shares during the period. Alliancebernstein L.P. increased its stake in shares of UnitedHealth Group by 5.2% during the fourth quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock worth $4,027,639,000 after buying an additional 569,142 shares during the period. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $3,397,896,000. Finally, Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 2.4% in the fourth quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock valued at $3,106,385,000 after purchasing an additional 207,865 shares in the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
In related news, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction on Thursday, February 11th. The shares were sold at an average price of $335.80, for a total transaction of $1,679,000.00. Following the completion of the sale, the director now directly owns 153,953 shares of the company’s stock, valued at approximately $51,697,417.40. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Patricia L. Lewis sold 3,000 shares of the firm’s stock in a transaction on Friday, April 16th. The shares were sold at an average price of $389.99, for a total transaction of $1,169,970.00. Following the sale, the executive vice president now directly owns 9,214 shares of the company’s stock, valued at $3,593,367.86. The disclosure for this sale can be found here. Insiders sold 12,619 shares of company stock valued at $4,462,744 in the last three months. Company insiders own 0.80% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.38 by $0.93. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The company had revenue of $70.20 billion during the quarter, compared to analyst estimates of $69.13 billion. During the same quarter in the prior year, the business earned $3.72 earnings per share. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.28%. The ex-dividend date was Friday, March 12th. UnitedHealth Group’s payout ratio is currently 33.09%.
A number of research firms have commented on UNH. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a research note on Friday. Bank of America restated a “buy” rating and set a $415.00 target price on shares of UnitedHealth Group in a research report on Thursday, January 21st. Truist upped their price target on shares of UnitedHealth Group from $420.00 to $450.00 in a report on Wednesday, April 14th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $462.00 to $515.00 and gave the company an “overweight” rating in a report on Friday. Finally, BMO Capital Markets upped their price target on shares of UnitedHealth Group from $410.00 to $435.00 and gave the company a “market perform” rating in a report on Friday. Four research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $407.77.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
See Also: No Load Funds
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.